薛 伶珊

Medicine & Life Sciences

1. Bacteremia 69%
2. Infections 59%
3. Carbapenems 53%
4. Aeromonas 39%
5. Multicenter Studies 36%
6. Coronavirus 34%
7. Pneumonia 31%
8. Cefepime 27%
9. Mortality 26%
10. Hepacivirus 25%
11. Autoantibodies 25%
12. Aeromonas veronii 24%
13. Macau 23%
14. SARS Virus 20%
15. Olfaction Disorders 19%
16. Legionnaires' Disease 19%
17. Cross Infection 19%
18. HIV 19%
19. Intraabdominal Infections 18%
20. Mycobacterium Infections 18%
21. Hand Hygiene 18%
22. Vancomycin-Resistant Enterococci 18%
23. Vibrio 17%
24. Clostridium Infections 17%
25. carbapenemase 17%
26. Salmonella Infections 17%
27. Sick Leave 16%
28. Anti-Bacterial Agents 16%
29. Candidiasis 16%
30. Fever 16%
31. Olfactory Bulb 15%
32. Dengue 15%
33. Therapeutics 14%
34. Zoonoses 14%
35. Retrospective Studies 14%
36. Pandemics 14%
37. Oligonucleotide Array Sequence Analysis 14%
38. Lymphadenopathy 14%
39. RNA 14%
40. Cough 13%
41. Genotype 13%
42. Interferons 12%
43. Soft Tissue Infections 12%
44. Mass Spectrometry 12%
45. Interferon-gamma 12%